ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 109451 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 109451; 2) Community: the network communities that were significantly associated with the response to NSC 109451; 3) Molecule: the relationships between components within communities and NSC 109451; 4) MDR: the compounds that were significantly associated with the NSC 109451.

NSC Compound Enrichment Correlation
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.0102077332082017 -0.076544098
NSC 750501 1,5-bis[4-(N-butylamidino)phenoxy]-3-tiapentane dihydrochloride 0.0102077332082017 0.092246427
NSC 762009 Copper(II) complex with quin as a ligand 0.0102077332082017 -0.18564596
NSC 12198 Dromostanolone Propionate 0.0102962192514438 -0.12534371
NSC 127128 Null 0.0102962192514438 0.44003114
NSC 22348 1H-Naphth[2,3-d]imidazole-4,9-dione, 1-(p-bromophenyl)- 2-methyl- 0.0102962192514438 -0.13479421
NSC 254677 Phomazarin 0.0102962192514438 0.42206618
NSC 294979 BLEOMYCIN-BAPP 0.0102962192514438 0.41526849
NSC 295641 Hydrazinecarbodithioic acid, [1-(2-pyridinyl)ethylidene]-, phenylmethyl ester 0.0102962192514438 -0.19313598
NSC 339638 2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt 0.0102962192514438 -0.48298552
Total:114  Current:29    [First] [Prev] [Next] [Last]